Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review. Gomez-Lumbreras A, Ghule P, Panchal R, Giannouchos T, et al. Int Ophthalmol 2023 Aug 22. doi: 10.1007/s10792-023-02853.

Read + Share

Amedeo Smart

Independent Medical Education

Gomez-Lumbreras A, Ghule P, Panchal R, Giannouchos T, et al. Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review. Int Ophthalmol 2023 Aug 22. doi: 10.1007/s10792-023-02853.
PMID: 37606820